ECSTACY: A Review of MDMA and MDA

@article{Climko1986ECSTACYAR,
  title={ECSTACY: A Review of MDMA and MDA},
  author={Robert P. Climko and H. Roehrich and Donald R. Sweeney and J Alrazi},
  journal={The International Journal of Psychiatry in Medicine},
  year={1986},
  volume={16},
  pages={359 - 372}
}
The Drug Enforcement Administration classified the drug methylenedioxymeth-amphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl… 

Figures from this paper

MDMA (Ecstacy): Useful Information for Health Professionals Involved in Drug Education Programs
  • C. Elk
  • Biology
    Journal of drug education
  • 1996
TLDR
Despite reports of an increase in MDMA usage among adolescents and young adults in the past decade, systematic scientific information concerning MDMA and its effects remains insufficient, thus limiting or eliminating MDMA from inclusion in the drug education curriculum.
An Exploration of the History and Controversies Surrounding MDMA and MDA
  • A. Pentney
  • Psychology
    Journal of psychoactive drugs
  • 2001
TLDR
A look at the history of these compounds suggests that they have the potential to be used safely as psychotherapeutic tools, and that the legal status of MDMA and MDA may be worth reconsidering.
Human Deaths and Toxic Reactions Attributed to MDMA and MDEA
TLDR
MDMA and MDEA are synthetic amphetamine analogues that have received considerable media attention as recreational drugs popular among college students and young professionals and well-documented deaths related to the use of these two drugs are exceptionally rare.
Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
TLDR
This review examines the existing literature on a host of entactogenic drugs, which may prove to be useful alternatives to MDMA, paying particularly close attention to any neurotoxic risks, neuropharmacological mechanism of action andEntactogenic commonalities with MDMA.
3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
  • H. Kalant
  • Medicine, Psychology
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
  • 2001
TLDR
The available evidence does not yet permit an accurate assessment of the size of the problem presented by the use of these drugs, but a detailed review of the literature has revealed over 87 "ecstasy"-related fatalities.
M.D.M.A. (“Ecstasy”); a case of possible drug-induced psychosis
TLDR
A case of prolonged psychosis following brief recreational use of Ecstasy is reported, and it is reported that Ecstasy has been increasingly abused in Dublin in recent years.
Performance Enhancement and Adverse Consequences of MDMA
SUMMARY Since its emergence as a recreational club drug in the 1970s, 3-4 methylenedioxy-methamphetamine's usage, more commonly known as ecstasy or MDMA, has risen rapidly through the 1990s, mainly
3 , 4-Methylenedioxy analogues of amphetamine : Defining the risks to humans
TLDR
A review examines the relevant human and animal literature to delineate the possible risks MDMA, MDA and MDE engender with oral consumption in humans and the potential for drug–drug interactions associated with acute and chronic use.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 57 REFERENCES
Another abusable amphetamine.
TLDR
Physically, the only visible change described was widely dilated pupils, however, subjectively, the patients described a mild sense of physical well-being with some increase in taste sensation, accompanied by a feeling of "numbness" or a decreased awareness of bodily sensations.
Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology.
TLDR
The patient's condition was initially stabilized and then deteriorated with uncontrollable hyperthermia, hematologic abnormalities, and coma that culminated in death, so phentolamine (Regitine) mesylate may be the preferred drug to be used in the treatment of future cases.
3,4-methylenedioxyamphetamine (MDA): analytical and forensic aspects of fatal poisoning.
  • G. Cimbura
  • Medicine
    Journal of forensic sciences
  • 1972
TLDR
In spite of this tight control, MDA, known as the “love pill,” has apparently become popular in the drug oriented segment of the authors' society.
Near fatal reaction to ingestion of the hallucinogenic drug MDA.
TLDR
Three cases reported here document a near fatal, a severe, and a mild adverse reaction to ingestion of a single 500 mg capsule of pure MDA.
Fatal intoxication from 3,4-methylenedioxyamphetamine.
The symptoms of MDA intoxication exhibited by the decedent prior to death closely mimic those of acute amphetamine poisoning: profuse sweating, violent and irrational behavior, and stereotypically
PMA deaths in Ontario.
  • G. Cimbura
  • Medicine
    Canadian Medical Association journal
  • 1974
TLDR
A new street-drug, para-methoxyamphetamine (PMA), recently made its appearance in Ontario and appears to have a powerful hallucinogenic effect as well as a marked toxicity to the central nervous system.
MDA and DOM: Substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat
  • H. Shannon
  • Biology, Psychology
    Psychopharmacology
  • 2004
TLDR
Neither MDA nor DOM produced any amphetamine-appropriate responding when tested over a 30-fold dose range, suggesting that neither MDA or DOM should be classed as Amphetamine-like agents.
...
1
2
3
4
5
...